;PMID: 9717176
;source_file_1780.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..34] = [t:0..34]
;1)sentence:[e:40..196] = [t:40..196]
;2)section:[e:200..220] = [t:200..220]
;3)section:[e:224..315] = [t:224..315]
;4)sentence:[e:319..521] = [t:319..521]
;5)sentence:[e:522..586] = [t:522..586]
;6)sentence:[e:587..649] = [t:587..649]
;7)sentence:[e:650..833] = [t:650..833]
;8)sentence:[e:834..893] = [t:834..893]
;9)sentence:[e:894..947] = [t:894..947]
;10)sentence:[e:948..1021] = [t:948..1021]
;11)sentence:[e:1022..1209] = [t:1022..1209]
;12)sentence:[e:1210..1359] = [t:1210..1359]
;13)sentence:[e:1360..1477] = [t:1360..1477]
;14)section:[e:1481..1525] = [t:1481..1525]

;section 0 Span:0..34
;Mutagenesis. 1998 Jul;13(4):385-9.
(SEC
  (FRAG (NN:[0..11] Mutagenesis) (.:[11..12] .) (CD:[13..17] 1998)
        (CC:[18..25] Jul;13-LRB-) (CD:[25..26] 4) (-RRB-:[26..27] -RRB-)
        (::[27..28] :) (CD:[28..31] 385) (::[31..32] -) (CD:[32..34] 9.)))

;sentence 1 Span:40..196
;Inhibition of metabolic activation of the promutagens, benzo[a]pyrene, 
;2-aminofluorene and 2-aminoanthracene by furanochromones in Salmonella 
;typhimurium.
;[82..93]:substance:"promutagens"
;[95..109]:substance:"benzo[a]pyrene"
;[112..127]:substance:"2-aminofluorene"
;[132..149]:substance:"2-aminoanthracene"
;[153..168]:substance:"furanochromones"
(SENT
  (NP-HLN
    (NP (NN:[40..50] Inhibition))
    (PP (IN:[51..53] of)
      (NP
        (NP (JJ:[54..63] metabolic) (NN:[64..74] activation))
        (PP (IN:[75..77] of)
          (NP
            (NP (DT:[78..81] the) (NNS:[82..93] promutagens))
            (,:[93..94] ,)
            (NP (NN:[95..109] benzo-LSB-a-RSB-pyrene) (,:[109..110] ,)
                (NN:[112..127] 2-aminofluorene) (CC:[128..131] and)
                (NN:[132..149] 2-aminoanthracene))))))
    (PP (IN:[150..152] by)
      (NP (NNS:[153..168] furanochromones)))
    (PP-LOC (IN:[169..171] in)
      (NP (NNP:[172..182] Salmonella) (NNP:[184..195] typhimurium)))
    (.:[195..196] .)))

;section 2 Span:200..220
;Schimmer O, Rauch P.
(SEC
  (FRAG (NNP:[200..208] Schimmer) (NNP:[209..210] O) (,:[210..211] ,)
        (NNP:[212..217] Rauch) (NNP:[218..220] P.)))

;section 3 Span:224..315
;Institut fur Botanik und Pharmazeutische Biologie, Universitat 
;Erlangen-Nurnberg, Germany.
(SEC
  (FRAG (NNP:[224..232] Institut) (NN:[233..236] fur) (NNP:[237..244] Botanik)
        (VBD:[245..248] und) (NNP:[249..264] Pharmazeutische)
        (NNP:[265..273] Biologie) (,:[273..274] ,) (NNP:[275..286] Universitat)
        (NNP:[288..297] Erlangen-) (NNP:[297..305] Nurnberg) (,:[305..306] ,)
        (NNP:[307..314] Germany) (.:[314..315] .)))

;sentence 4 Span:319..521
;Khellin, a naturally occurring furanochromone (Ammi visnaga fruits),
;inhibited  the mutagenicity of the promutagens benzo[a]pyrene,
;2-aminofluorene and  2-aminoanthracene in Salmonella typhimurium TA98.
;[319..326]:substance:"Khellin"
;[350..364]:substance:"furanochromone"
;[423..434]:substance:"promutagens"
;[435..449]:substance:"benzo[a]pyrene"
;[451..466]:substance:"2-aminofluorene"
;[472..489]:substance:"2-aminoanthracene"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[319..326] Khellin))
      (,:[326..327] ,)
      (NP
        (NP (DT:[328..329] a)
          (ADJP (RB:[330..339] naturally) (VBG:[340..349] occurring))
          (NN:[350..364] furanochromone))
        (NP (-LRB-:[365..366] -LRB-) (NNP:[366..370] Ammi)
            (NNP:[371..378] visnaga) (NNS:[379..385] fruits)
            (-RRB-:[385..386] -RRB-))))
    (,:[386..387] ,)
    (VP (VBD:[388..397] inhibited)
      (NP
        (NP (DT:[399..402] the) (NN:[403..415] mutagenicity))
        (PP (IN:[416..418] of)
          (NP
            (NP (DT:[419..422] the) (NNS:[423..434] promutagens))
            (NP (NN:[435..449] benzo-LSB-a-RSB-pyrene) (,:[449..450] ,)
                (NN:[451..466] 2-aminofluorene) (CC:[467..470] and)
                (NN:[472..489] 2-aminoanthracene)))))
      (PP-LOC (IN:[490..492] in)
        (NP (NNP:[493..503] Salmonella) (NNP:[504..515] typhimurium)
            (NN:[516..520] TA98))))
    (.:[520..521] .)))

;sentence 5 Span:522..586
;The effect varied greatly and  depended on the S9 fraction used.
(SENT
  (S
    (NP-SBJ (DT:[522..525] The) (NN:[526..532] effect))
    (VP
      (VP (VBD:[533..539] varied)
        (ADVP (RB:[540..547] greatly)))
      (CC:[548..551] and)
      (VP (VBD:[553..561] depended)
        (PP-CLR (IN:[562..564] on)
          (NP
            (NP (DT:[565..568] the) (NN:[569..571] S9) (NN:[572..580] fraction))
            (VP (VBN:[581..585] used)
              (NP (-NONE-:[585..585] *)))))))
    (.:[585..586] .)))

;sentence 6 Span:587..649
;Cytosolic activation of 2-aminoanthracene was  also inhibited.
;[611..628]:substance:"2-aminoanthracene"
(SENT
  (S
    (NP-SBJ-1
      (NP (JJ:[587..596] Cytosolic) (NN:[597..607] activation))
      (PP (IN:[608..610] of)
        (NP (NN:[611..628] 2-aminoanthracene))))
    (VP (VBD:[629..632] was)
      (ADVP (RB:[634..638] also))
      (VP (VBN:[639..648] inhibited)
        (NP-1 (-NONE-:[648..648] *))))
    (.:[648..649] .)))

;sentence 7 Span:650..833
;Khellin produced no effect or only weak activity against the  direct acting
;mutagens 2-nitrofluorene, 4-nitro-o-phenylenediamine,  1-nitropyrene and
;ethylmethane sulfonate (in TA100).
;[650..657]:substance:"Khellin"
;[726..734]:substance:"mutagens"
;[735..750]:substance:"2-nitrofluorene"
;[752..778]:substance:"4-nitro-o-phenylenediamine"
;[781..794]:substance:"1-nitropyrene"
;[799..821]:substance:"ethylmethane sulfonate"
(SENT
  (S
    (NP-SBJ (NN:[650..657] Khellin))
    (VP (VBD:[658..666] produced)
      (NP
        (NP (DT:[667..669] no) (NN:[670..676] effect))
        (CC:[677..679] or)
        (NP (RB:[680..684] only) (JJ:[685..689] weak) (NN:[690..698] activity))
        (PP (IN:[699..706] against)
          (NP
            (NP (DT:[707..710] the)
              (ADJP (JJ:[712..718] direct) (VBG:[719..725] acting))
              (NNS:[726..734] mutagens))
            (NP
              (NP (NN:[735..750] 2-nitrofluorene))
              (,:[750..751] ,)
              (NP (NN:[752..778] 4-nitro-o-phenylenediamine))
              (,:[778..779] ,)
              (NP (NN:[781..794] 1-nitropyrene))
              (CC:[795..798] and)
              (NP
                (NP (NN:[799..811] ethylmethane) (NN:[812..821] sulfonate))
                (PRN (-LRB-:[822..823] -LRB-)
                  (PP (IN:[823..825] in)
                    (NP (NN:[826..831] TA100)))
                  (-RRB-:[831..832] -RRB-))))))))
    (.:[832..833] .)))

;sentence 8 Span:834..893
;Daunomycin mutagenicity was  inhibited to a greater extent.
;[834..844]:substance:"Daunomycin"
(SENT
  (S
    (NP-SBJ-1 (NN:[834..844] Daunomycin) (NN:[845..857] mutagenicity))
    (VP (VBD:[858..861] was)
      (VP (VBN:[863..872] inhibited)
        (NP-1 (-NONE-:[872..872] *))
        (PP (TO:[873..875] to)
          (NP (DT:[876..877] a) (JJR:[878..885] greater) (NN:[886..892] extent)))))
    (.:[892..893] .)))

;sentence 9 Span:894..947
;Visnagin was more toxic, but showed similar  effects.
;[894..902]:substance:"Visnagin"
(SENT
  (S
    (NP-SBJ (NN:[894..902] Visnagin))
    (VP
      (VP (VBD:[903..906] was)
        (ADJP-PRD (RBR:[907..911] more) (JJ:[912..917] toxic)))
      (,:[917..918] ,) (CC:[919..922] but)
      (VP (VBD:[923..929] showed)
        (NP (JJ:[930..937] similar) (NNS:[939..946] effects))))
    (.:[946..947] .)))

;sentence 10 Span:948..1021
;Khellol and its glucoside were inactive against all the mutagens  tested.
;[948..955]:substance:"Khellol"
;[964..973]:substance:"glucoside"
;[1004..1012]:substance:"mutagens"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[948..955] Khellol))
      (CC:[956..959] and)
      (NP (PRP$:[960..963] its) (NN:[964..973] glucoside)))
    (VP (VBD:[974..978] were)
      (ADJP-PRD (JJ:[979..987] inactive)
        (PP (IN:[988..995] against)
          (NP (PDT:[996..999] all) (DT:[1000..1003] the)
              (NNS:[1004..1012] mutagens)
            (VP (VBN:[1014..1020] tested)
              (NP (-NONE-:[1020..1020] *)))))))
    (.:[1020..1021] .)))

;sentence 11 Span:1022..1209
;We conclude that khellin acts as an inhibitor or the microsomal  cytochrome
;P450 sub-enzymes analogous to the related furanocoumarins and is also 
;capable of inhibiting cytosolic enzymes.
;[1039..1046]:substance:"khellin"
;[1058..1067]:substance:"inhibitor"
;[1087..1114]:cyp450:"cytochrome P450 sub-enzymes"
;[1140..1155]:substance:"furanocoumarins"
;[1201..1208]:substance:"enzymes"
(SENT
  (S
    (NP-SBJ (PRP:[1022..1024] We))
    (VP (VBP:[1025..1033] conclude)
      (SBAR (IN:[1034..1038] that)
        (S
          (NP-SBJ-1 (NN:[1039..1046] khellin))
          (VP
            (VP (VBZ:[1047..1051] acts)
              (PP-MNR (IN:[1052..1054] as)
                (NP
                  (NP (DT:[1055..1057] an) (NN:[1058..1067] inhibitor))
                  (CC:[1068..1070] or)
                  (NP
                    (NP (DT:[1071..1074] the) (JJ:[1075..1085] microsomal)
                      
                      (NML (NN:[1087..1097] cytochrome) (NN:[1098..1102] P450))
                      (AFX:[1103..1106] sub) (HYPH:[1106..1107] -)
                       (NNS:[1107..1114] enzymes))
                    (ADJP (JJ:[1115..1124] analogous)
                      (PP (TO:[1125..1127] to)
                        (NP (DT:[1128..1131] the) (VBN:[1132..1139] related)
                            (NNS:[1140..1155] furanocoumarins))))))))
            (CC:[1156..1159] and)
            (VP (VBZ:[1160..1162] is)
              (ADVP (RB:[1163..1167] also))
              (ADJP-PRD (JJ:[1169..1176] capable)
                (PP (IN:[1177..1179] of)
                  (S-NOM
                    (NP-SBJ-1 (-NONE-:[1179..1179] *))
                    (VP (VBG:[1180..1190] inhibiting)
                      (NP (JJ:[1191..1200] cytosolic) (NNS:[1201..1208] enzymes)))))))))))
    (.:[1208..1209] .)))

;sentence 12 Span:1210..1359
;The extract from Ammi visnaga fruits  showed a higher inhibition potency than
;khellin alone against 2-aminoanthracene,  1-nitropyrene and daunomycin.
;[1214..1221]:substance:"extract"
;[1227..1246]:substance:"Ammi visnaga fruits"
;[1288..1295]:substance:"khellin"
;[1310..1327]:substance:"2-aminoanthracene"
;[1330..1343]:substance:"1-nitropyrene"
;[1348..1358]:substance:"daunomycin"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1210..1213] The) (NN:[1214..1221] extract))
      (PP (IN:[1222..1226] from)
        (NP
          (NML (NNP:[1227..1231] Ammi) (NNP:[1232..1239] visnaga))
          (NNS:[1240..1246] fruits))))
    (VP (VBD:[1248..1254] showed)
      (NP
        (NP (DT:[1255..1256] a) (JJR:[1257..1263] higher)
            (NN:[1264..1274] inhibition) (NN:[1275..1282] potency))
        (PP (IN:[1283..1287] than)
          (NP
            (NP (NN:[1288..1295] khellin))
            (ADVP (RB:[1296..1301] alone))
            (PP (IN:[1302..1309] against)
              (NP (NN:[1310..1327] 2-aminoanthracene) (,:[1327..1328] ,)
                  (NN:[1330..1343] 1-nitropyrene) (CC:[1344..1347] and)
                  (NN:[1348..1358] daunomycin)))))))
    (.:[1358..1359] .)))

;sentence 13 Span:1360..1477
;This might be due to additional inhibitors, e.g.  coumarins, or to the
;synergistic effects of accompanying compounds.
;[1392..1402]:substance:"inhibitors"
;[1410..1419]:substance:"coumarins"
;[1467..1476]:substance:"compounds"
(SENT
  (S
    (NP-SBJ (DT:[1360..1364] This))
    (VP (MD:[1365..1370] might)
      (VP (VB:[1371..1373] be)
        (PP-PRD (IN:[1374..1377] due)
          (PP
            (PP (TO:[1378..1380] to)
              (NP
                (NP (JJ:[1381..1391] additional) (NNS:[1392..1402] inhibitors))
                (,:[1402..1403] ,)
                (NP
                  (ADVP (FW:[1404..1408] e.g.))
                  (NNS:[1410..1419] coumarins))))
            (,:[1419..1420] ,) (CC:[1421..1423] or)
            (PP (TO:[1424..1426] to)
              (NP
                (NP (DT:[1427..1430] the) (JJ:[1431..1442] synergistic)
                    (NNS:[1443..1450] effects))
                (PP (IN:[1451..1453] of)
                  (NP (VBG:[1454..1466] accompanying)
                      (NNS:[1467..1476] compounds)))))))))
    (.:[1476..1477] .)))

;section 14 Span:1481..1525
;PMID: 9717176 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1481..1485] PMID) (::[1485..1486] :) (CD:[1487..1494] 9717176)
        (NN:[1495..1496] -LSB-) (NNP:[1496..1502] PubMed) (::[1503..1504] -)
        (NN:[1505..1512] indexed) (IN:[1513..1516] for)
        (NNP:[1517..1525] MEDLINE-RSB-)))
